Study on Oleclumab and Durvalumab for Treating Sarcoma That Has Returned, Not Responded, or Spread | Clinical Trial

Study on Oleclumab and Durvalumab for Treating Sarcoma That Has Returned, Not Responded, or Spread | Clinical Trial | Right2Hope